½ÃÀ庸°í¼­
»óǰÄÚµå
1768087

¼¼°èÀÇ ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½º À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Healthcare Contract Research Outsourcing Market, By Services Type, By End User (CROs, Clinical Trial Laboratories, and AMCs), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀåÀº 2025³â¿¡´Â 1,726¾ï 3,000¸¸ ´Þ·¯, 2032³â¿¡´Â 4,620¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 15.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 1,726¾ï 3,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 15.10% 2032³â °¡Ä¡ ¿¹Ãø 4,620¾ï ´Þ·¯

ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½ÌÀº ½Å¾à ¹× ÀÇ·á±â±â °³¹ßÀ» À§ÇØ Á¦¾à ¹× ÀÇ·á±â±â ºÎ¹®¿¡¼­ ¼öÇàµÇ°í ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀº ÀǾàǰ ¹× ÀÇ·á±â±â °³¹ßÀÇ ÁÖ¿ä ºÎºÐÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, ÇöÀç ½Ã³ª¸®¿À¿¡¼­ ÀÓ»ó½ÃÇèÀº ´Ù¾çÇÑ Áö¿ªÀÇ ¿©·¯ Àå¼Ò¿¡¼­ ¼öÇàµÇ°í ÀÖ½À´Ï´Ù. ÀǾàǰ °³¹ß¿¡ ÇÊ¿äÇÑ ºñ¿ë°ú ½Ã°£ °³¹ßÀº ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ÇコÄɾî R&D ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ÀǾàǰÀÇ Æ¯Çã°¡ ¸¸·áµÇ´Â ÀǾàǰÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

°øµ¿ ¿¬±¸ ¹× ÆÄÆ®³Ê½Ê Áõ°¡´Â ¼¼°è ÀÇ·á ¿¬±¸ ¼öŹ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 9¿ù¿¡´Â ¼¼°è ¿£µåÅõ¿£µå °³¹ß ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÀÇ·á±â±â ¿¬±¸°³¹ß ¼öʱâ°ü(CRO)ÀÎ North American Science Associates, LLC(NAMSA)¿Í °æµ¿¸Æ Áúȯ Ä¡·á ¹× ³úÁ¹Áß ¿¹¹æÀ» ¸ñÀûÀ¸·Î ÇÏ´Â CGuard Embolic Prevention System(EPS) °³¹ß ±â¾÷ÀÎ InspireMD, Inc.°¡ ÀÇ·á±â±â °³¹ß ¹× »ó¿ëÈ­¸¦ °¡¼ÓÈ­Çϱâ À§ÇÑ ¾Æ¿ô¼Ò½Ì ÆÄÆ®³Ê½ÊÀ» ü°áÇÏ¿´½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© 2025-2032³â°£ ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ °³¿ä, ½ÇÀû, Á¦Ç° Æ÷Æ®Æú¸®¿À, ½ÃÀå ÀÔÁö, À¯Åë Àü·«, ÁÖ¿ä °³¹ß, Àü·«, ¹Ì·¡ °èȹ µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ½ÃÀå ÁÖ¿ä ±â¾÷À¸·Î´Â IQVIA Inc., Covance Inc.(LabcorpÀÇ ÀÚȸ»ç), Pharmaceutical Product Development Inc. MA) Corporation, Charles River Laboratories, ICON plc, Medidata, Inventiv Health, Inc. Syneos HealthÀÇ ÀÚȸ»ç, Medpace, Pyramal Enterprises Ltd. µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ±â¼ú °³¼±, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±Ù Á¦Ç° ¸±¸®½º
  • ¿ªÇÐ
  • ÇÕº´, Àμö ¹× Çù¾÷
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀå, ¼­ºñ½º À¯Çüº°, 2020³â-2032³â

  • ÀÓ»ó½ÃÇè
  • ±ÔÁ¦ ¼­ºñ½º
  • ¸ÞµðÄà ¶óÀÌÆÃ
  • ÀÓ»ó µ¥ÀÌÅÍ °ü¸®
  • ±âŸ

Á¦5Àå ¼¼°èÀÇ ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â

  • CRO
  • ÀÓ»ó½ÇÇè½Ç
  • AMC

Á¦6Àå ¼¼°èÀÇ ÇコÄÉ¾î ¼öŹ¿¬±¸ ¾Æ¿ô¼Ò½Ì ½ÃÀå, Áö¿ªº°, 2020³â-2032³â

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

Á¦7Àå °æÀï ±¸µµ

  • IQVIA Inc.
  • Covance Inc(A subsidiary of Labcorp)
  • Pharmaceutical Product Development Inc(A subsidiary of Thermo Fisher Scientific Inc.)
  • Parexel International(MA) Corporation
  • Charles River Laboratories
  • ICON plc
  • Medidata
  • Inventiv Health, Inc.(A subsidiary of Syneos Health)
  • Medpace
  • Piramal Enterprises Ltd.

Á¦8Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 25.07.21

Healthcare Contract Research Outsourcing Market is estimated to be valued at USD 172.63 Bn in 2025 and is expected to reach USD 462.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 172.63 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.10% 2032 Value Projection: USD 462.00 Bn

Healthcare contract research outsourcing is conducted by the pharmaceutical and medical device sectors for the development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development, and in the current scenario, clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development are expected to propel the global healthcare contract research outsourcing market growth over the forecast period. Furthermore, the increasing number of patent expirations of leading drugs is also expected to aid in the growth of the market.

Market Dynamics

Increasing incidences of collaborations and partnerships are attributed to the growth of the global healthcare contract research outsourcing market. For instance, in September 2022, North American Science Associates, LLC (NAMSA), a Medical Devices Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc., a developer of the CGuard Embolic Prevention System (EPS) for the treatment of carotid artery disease and prevention of strokes, entered an outsourcing partnership to accelerate medical device development and commercialization.

Key features of the study

  • This report provides an in-depth analysis of the global healthcare contract research outsourcing market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global healthcare contract research outsourcing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
  • The key companies covered as a part of this study include, IQVIA Inc., Covance Inc (a subsidiary of Labcorp), Pharmaceutical Product Development Inc (a subsidiary of Thermo Fisher Scientific Inc), Parexel International (MA) Corporation, Charles River Laboratories, ICON plc, Medidata, Inventiv Health, Inc. (A subsidiary of Syneos Health), Medpace, and Piramal Enterprises Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global healthcare contract research outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare contract research outsourcing market.

Market Segmentation

  • Global Healthcare Contract Research Outsourcing Market, By Services Type
    • Clinical Trials
    • Regulatory Services
    • Medical Writing
    • Clinical Data Management
    • Others
  • Global Healthcare Contract Research Outsourcing Market, By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
  • Global Healthcare Contract Research Outsourcing Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • IQVIA Inc.
    • Covance Inc (A subsidiary of Labcorp)
    • Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
    • Parexel International (MA) Corporation
    • Charles River Laboratories
    • ICON plc
    • Medidata
    • Inventiv Health, Inc. (A subsidiary of Syneos Health)
    • Medpace
    • Piramal Enterprises Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Services Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Healthcare Contract Research Outsourcing Market, By Service Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Clinical Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
      • Drug Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
  • Regulatory Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Medical Writing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Clinical Data Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

5. Global Healthcare Contract Research Outsourcing Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • CROs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Clinical Trial Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • AMCs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

6. Global Healthcare Contract Research Outsourcing Market, By Region, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • IQVIA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance Inc (A subsidiary of Labcorp)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Parexel International (MA) Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ICON plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medidata
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inventiv Health, Inc. (A subsidiary of Syneos Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medpace
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Piramal Enterprises Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦